Carbon Monoxide Migraine-inducing Effects in Patients With Migraine Without Aura.

NCT03075020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-12-21

No results posted yet for this study

Summary

To investigate headache score and accompanying symptoms during and after inhalation of carbon monoxide.

Conditions

  • Headache, Migraine

Interventions

OTHER

Carbon monoxide

carbon monoxide, 4.7, Purity 99.997, inhalation of carbon monoxide in a volume corresponding to carboxyhemoglobin 10 and 20%, calculated from baseline Hg and body mass

OTHER

AIR

Room air will be administered as placebo

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-08-31
Completion
2017-12-20

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075020 on ClinicalTrials.gov